Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 804 results for "alexion pharmaceuticals"

10-K/A - ALEXION PHARMACEUTICALS INC (0000899866) (Filer)

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405] [Amend] SEC Accession No. 0000899866-17-000012 Filing Date 2017-01-19 2017-01-19 17:14:33 Period of Report 2015-12-31 Filing Date Changed 2017-01-19 Document ... SEC Filings, 23 hours ago

130 images for alexion pharmaceuticals

American Banking News, 6 days ago
Ticker Report, 4 days ago
Ticker Report, 6 days ago
American Banking News, 6 days ago
American Banking News, 2 weeks ago
Analyst Ratings.com, 2 weeks ago
American Banking News, 2 weeks ago
WKRB News, 3 weeks ago
StatNews.com, 2 days ago
Freshnews.com, 6 days ago
Nasdaq

Alexion Pharmaceuticals (ALXN) presents at 35th Annual J.P. Morgan Healthcare Conference

Jan.10.17 | About: Alexion Pharmaceuticals, (ALXN) The following slide deck was published by Alexion Pharmaceuticals, Inc. in conjunction with this event. Click
 Seeking Alpha1 week ago Alexion to Present at the 35th Annual J.P. Morgan Healthcare Conference  Pharmacy Choice4 days ago Alexion Pharmaceuticals To Present At J.P.Morgan Conference; Webcast At 11:00 AM  Nasdaq1 week ago ALEXION PHARMACEUTICALS : to Present at the 35th Annual J.P. Morgan Healthcare Conference  4 Traders2 weeks ago
[x]  
Freshnews.com

ALEXION PHARMACEUTICALS : Submits U.S. and EU Applications Seeking Approval of Soliris® Eculizumab as a Treatment for Patients with Refractory Generalized Myasthenia...

Alexion Submits U.S. and EU Applications Seeking Approval of Soliris® Eculizumab as a Treatment for Patients with Refractory Generalized Myasthenia Gravis gMG By a News Reporter-Staff News Editor at Biotech Week -- Alexion Pharmaceuticals, Inc.
 4 Traders1 day ago Alexion Pharmaceuticals Files Form 10-Q for Third Quarter 2016  Freshnews.com6 days ago Alexion submits marketing applications for expanded use of Soliris  Seeking Alpha1 week ago Alexion Pharma Announces Regulatory Submissions To Extend Indication For Soliris  Quotenet.com1 week ago
[x]  

BRIEF-Alexion interim CEO says company is not up for sale - conf (ALXN)

Jan 9 (Reuters) - Alexion Pharmaceuticals Inc * Alexion interim CEO says they are not up for sale - JPM Healthcare conf * Alexion execs says growth is primarily coming from volume, not pricing- JPM Healthcare conf * Alexion execs say they are ...
 Business Insider1 week ago
Motley Fool

Here's Why Alexion Pharmaceuticals, Inc. Stock Gave Up 36% in 2016

Image source: . What happened Shares of rare-disease specialist Alexion Pharmaceuticals, Inc. ( NASDAQ:ALXN ) slid 35.9% lower last year, according to data from S&P Global Market Intelligence . Disturbing clinical trial results for its lead ...
 Motley Fool1 week ago
Nasdaq

Company News for January 06, 2017

• Alexion Pharmaceuticals, Inc's (ALXN) shares jumped 9.5% after forecasting earnings within the range of $4.50 to $4.65 per share for 2016, higher than the Zacks Consensus Estimate of $3.86 • Shares of CEB Inc. (CEB) climbed 20.9% following ...
 Yahoo! Finance2 weeks ago
[x]  
International Business Times

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. - ALXN

NEW YORK, Jan. 12, 2017 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Alexion Pharmaceuticals, Inc. securities (NASDAQ: ALXN) from February 10, 2014 ...
 International Business Times1 week ago ALEXION 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Alexion Pharmaceuticals, Inc. (ALXN)  4 Traders6 days ago Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. - ALXN  4 Traders1 week ago Alexion faults tone at top, management pressure in Soliris investigation  BioPharma Dive2 weeks ago
[x]  
CNBC

Alexion shares zoom higher after sales probe ends

Shares of drugmaker Alexion Pharmaceuticals jumped more than 9 percent on Thursday after the company reiterated its 2016 forecast and said an internal investigation ended. In a Securities and Exchange Commission filing, Alexion said it continues to ...
 CNBC2 weeks ago Alexion shares zoom higher as sales probe ends with no need for restatement, backs 2016 forecast  Yahoo! Finance UK and Ireland2 weeks ago

Alexion Moves Notably Higher After Reaffirming Guidance

Drug company Alexion Pharmaceuticals (ALXN) has moved notably higher during trading on Thursday, advancing by 9.7 percent. Alexion reached a two-month intraday high earlier in the session. The advance by shares of Alexion comes after the company ...
 RTTNews.com2 weeks ago

Bay State Biotech Report: Alexion's Sales and Subpoena

Alexion Pharmaceuticals is speaking out about an internal investigation of its drug sales, and discloses a U.S. Attorney subpoena. That's on the Bay State Biotech Report, where Bloomberg biotechnology reporter Doni Bloomfield and Boston radio host ...
 Bloomberg2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less